Therapy monitoring with PET in cancer patients: achievements, opportunities and challenges ahead for the PET community

Therapy monitoring with PET in cancer patients: achievements, opportunities and challenges ahead... Eur J Nucl Med Mol Imaging (2017) 44 (Suppl 1):S1–S3 DOI 10.1007/s00259-017-3721-5 EDITORIAL Therapy monitoring with PET in cancer patients: achievements, opportunities and challenges ahead for the PET community 1,2,3 3,4 Nicolas Aide & Stefano Fanti Received: 3 May 2017 /Accepted: 5 May 2017 /Published online: 24 May 2017 Springer-Verlag Berlin Heidelberg 2017 It has been 18 years since the first guidelines on PET response We have divided the issue into four sections. The first sec- criteria were released [1] (with little supporting data at that tion includes a recent update on PET technologies and two time) and 15 years since the first successful use of PET for articles discussing the motivations and methodology for har- evaluation of a molecularly targeted therapy (imatinib) was monization of PET data and the challenges faced when published [2]. This latter study demonstrated the huge poten- implementing PET in clinical trials. It is followed by a section tial of PET imaging in assessing tumor response early after including a practical guide to better understand molecularly treatment initiation, at a time when conventional criteria based targeted therapies, and a comprehensive review on the use of on size measurements (RECIST) were found to be unsatisfac- http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Nuclear Medicine and Molecular Imaging Springer Journals

Therapy monitoring with PET in cancer patients: achievements, opportunities and challenges ahead for the PET community

Loading next page...
 
/lp/springer-journals/therapy-monitoring-with-pet-in-cancer-patients-achievements-qZCxSQ4UeU
Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Nuclear Medicine; Imaging / Radiology; Orthopedics; Cardiology; Oncology
ISSN
1619-7070
eISSN
1619-7089
D.O.I.
10.1007/s00259-017-3721-5
Publisher site
See Article on Publisher Site

Abstract

Eur J Nucl Med Mol Imaging (2017) 44 (Suppl 1):S1–S3 DOI 10.1007/s00259-017-3721-5 EDITORIAL Therapy monitoring with PET in cancer patients: achievements, opportunities and challenges ahead for the PET community 1,2,3 3,4 Nicolas Aide & Stefano Fanti Received: 3 May 2017 /Accepted: 5 May 2017 /Published online: 24 May 2017 Springer-Verlag Berlin Heidelberg 2017 It has been 18 years since the first guidelines on PET response We have divided the issue into four sections. The first sec- criteria were released [1] (with little supporting data at that tion includes a recent update on PET technologies and two time) and 15 years since the first successful use of PET for articles discussing the motivations and methodology for har- evaluation of a molecularly targeted therapy (imatinib) was monization of PET data and the challenges faced when published [2]. This latter study demonstrated the huge poten- implementing PET in clinical trials. It is followed by a section tial of PET imaging in assessing tumor response early after including a practical guide to better understand molecularly treatment initiation, at a time when conventional criteria based targeted therapies, and a comprehensive review on the use of on size measurements (RECIST) were found to be unsatisfac-

Journal

European Journal of Nuclear Medicine and Molecular ImagingSpringer Journals

Published: May 24, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off